Randomized Trial to Reduce Cardiovascular Risk in Women with Recent Preeclampsia.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of women's health"
DOI: 10.1089/jwh.2018.7523
Abstract: Background: To reduce cardiovascular disease (CVD) risk, we tested an online intervention to improve healthy lifestyle for women with recent preeclampsia. Methods: We conducted a randomized controlled 9-month clinical trial, Heart Health 4 Moms (HH4M),… read more here.
Keywords: risk; reduce cardiovascular; self efficacy; cvd risk ... See more keywords
Antihyperglycemic Therapies with Expansions of US Food and Drug Administration Indications to Reduce Cardiovascular Events: Prescribing Patterns within an Academic Medical Center.
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cardiovascular Pharmacology"
DOI: 10.1097/fjc.0000000000000864
Abstract: Sodium-glucose co-transport protein-2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) have been shown to reduce cardiovascular events in high-risk patients with type 2 diabetes mellitus (T2DM). We examined real-world use of these agents at… read more here.
Keywords: cardiovascular events; academic medical; reduce cardiovascular; cardiology ... See more keywords
Exercise Preferences for a Workplace Wellness Program to Reduce Cardiovascular Risk and Increase Work Productivity
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Occupational and Environmental Medicine"
DOI: 10.1097/jom.0000000000002608
Abstract: Most jobs for working-class adults are largely comprised of physically inactive tasks, increasing the risk for cardiovascular disease and less productivity. Workplace wellness programs can reduce this risk; however, recruitment and adherence to such programs… read more here.
Keywords: exercise preferences; wellness programs; reduce cardiovascular; risk ... See more keywords
PCSK9 Inhibitors in Cancer Patients Treated with Immune-Checkpoint Inhibitors to Reduce Cardiovascular Events: New Frontiers in Cardioncology
Sign Up to like & getrecommendations! Published in 2023 at "Cancers"
DOI: 10.3390/cancers15051397
Abstract: Simple Summary Atherosclerosis is a critical cardiovascular disease associated with the use of immune checkpoint inhibitors (ICIs). Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a key orchestrator of atherosclerotic process and it is also involved… read more here.
Keywords: checkpoint inhibitors; immune checkpoint; reduce cardiovascular; cancer patients ... See more keywords